Could a 'Love Hormone' spray ease anxiety in rare condition?
NCT ID NCT04789148
Summary
This study is testing whether a nasal spray containing oxytocin, sometimes called the 'love hormone,' can help improve anxiety, depression, and social functioning in adults with a rare hormone condition called vasopressin deficiency. In the first part, 40 participants will receive single doses of either oxytocin or a placebo spray during different visits, and their emotional responses will be measured. An optional second part will test if taking the spray three times a day for two weeks has a lasting benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOPRESSIN DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital, Neuroendocrine Unit
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.